kit is a qualitative real-time PCR (qPCR) assay for the detection of Herpes simplex virus 1 (HSV-1), Herpes simplex virus 2 (HSV-2), Varicella zoster virus (VZV) and Treponema pallidum. PlexPCR® VHS based on the Class-leading PlexPCR® technology utilising two proprietary technologies: PlexZyme® and PlexPrime®. This technology enables high performance and reliable multiplex qPCR compared to other probe-based methods.

Targets Single well, Herpes simplex virus 1 (HSV-1), Herpes simplex virus 2 (HSV-2), Varicella zoster virus (VZV), Treponema pallidum (Syphilis) & Internal Control
Validated Sample Types Swabs (genital, non-genital, anal/rectal and oral)
Storage & Stability Expiry dates are stated on the labels. It is recommended that freeze/thaw cycles be limited to less than 15. Store protected from light at – 20°C.
Validated RT-PCR Systems LightCycler® 480 Instrument II (LC480 II, Roche), Applied Biosystems® 7500 Fast (7500 Fast), Bio-Rad CFX96™ IVD (CFX96 IVD), Bio-Rad CFX96™ CFX96 Touch™ (CFX96 Touch)
Package Size 100 reactions/box
PlexPCR VHS Scientific Brochure 2022-05-25 17:58:54 428,74 KB
PlexPCR VHS Product Brochure 2022-05-25 17:59:39 543,54 KB

Sexually Transmitted Infections

Why use ?

Syphilis rates are increasing around the globe and symptomatic or visual lesion diagnostic approaches may be missing some cases presenting as an atypical lesion. Molecular diagnostics are recommended for management of genital lesions to improve diagnostic accuracy and subsequent patient management.

• Ulcerations or lesions in the ano-genital and oral regions can be caused by a variety of bacterial and viral infectious agents.

• Syphilis lesions can present atypically, be painful, and appear indistinguishable from herpes.

• Up to 3% of genital lesions may be atypical zoster (VZV) presentations.

Validated on hundreds of clinical samples,  demonstrates excellent sensitivity and specificity.